Champions Oncology, Inc. (CSBR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Champions Oncology, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 20.78x | -9.03x | -12.34x | 184.95x | 389.45x | -43.68x |
| P/B Ratio | 25.89x | -34.53x | 14.20x | 11.14x | 18.98x | 17.93x |
| P/S Ratio | 1.72x | 1.31x | 1.22x | 2.06x | 3.44x | 2.85x |
| Profitability | ||||||
| Gross Margin | 47.3% | 41.4% | 45.2% | 51.9% | 47.7% | 47.1% |
| Operating Margin | 8.5% | -13.8% | -8.3% | 1.2% | 0.9% | -4.9% |
| Net Margin | 8.3% | -14.5% | -9.9% | 1.1% | 0.9% | -6.5% |
| EBITDA Margin | 11.1% | -10.8% | -3.8% | 6.1% | 4.9% | -2.3% |
| Liquidity | ||||||
| Current Ratio | 0.94x | 0.63x | 0.90x | 1.13x | 1.13x | 1.10x |
| Quick Ratio | 0.94x | 0.63x | 0.90x | 1.13x | 1.13x | 1.10x |
| Leverage | ||||||
| Debt/Equity | 1.62x | -3.90x | 1.85x | 1.04x | 1.29x | 0.74x |
YoY = year-over-year change. Source: FMP..